Cargando…

Serum IgG4 elevation in hyper-inflamed COVID-19 patients. Author's reply

Detalles Bibliográficos
Autores principales:	Della-Torre, Emanuel, Lanzillotta, Marco, Ramirez, Giuseppe Alvise, Dagna, Lorenzo, Tresoldi, Moreno
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Federation of Internal Medicine. Published by Elsevier B.V. 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8531494/ https://www.ncbi.nlm.nih.gov/pubmed/34711472 http://dx.doi.org/10.1016/j.ejim.2021.10.025

Ejemplares similares

Serum IgG4 level predicts COVID-19 related mortality
por: Della-Torre, Emanuel, et al.
Publicado: (2021)

Mavrilimumab for severe COVID-19 – Authors' reply
por: De Luca, Giacomo, et al.
Publicado: (2020)

Treating COVID-19 with colchicine in community healthcare setting
por: Della-Torre, Emanuel, et al.
Publicado: (2020)

Increase of circulating memory B cells after glucocorticoid-induced remission identifies patients at risk of IgG4-related disease relapse
por: Lanzillotta, Marco, et al.
Publicado: (2018)

IgG4-Related Disease of the Oral Cavity. Case Series from a Large Single-Center Cohort of Italian Patients
por: Rampi, Andrea, et al.
Publicado: (2020)

Respiratory Impairment Predicts Response to IL-1 and IL-6 Blockade in COVID-19 Patients With Severe Pneumonia and Hyper-Inflammation
por: Della-Torre, Emanuel, et al.
Publicado: (2021)

Antineutrophil cytoplasmic antibody positivity in IgG4-related disease: A case report and review of the literature
por: Della-Torre, Emanuel, et al.
Publicado: (2016)

Effect of anakinra in COVID-19 – Authors' reply
por: Cavalli, Giulio, et al.
Publicado: (2020)

Drug reaction with eosinophilia and systemic symptoms (DRESS) in patients with COVID-19
por: Ramirez, Giuseppe A., et al.
Publicado: (2021)

IL-1 and IL-6 inhibition affects the neutralising activity of anti-SARS-CoV-2 antibodies in patients with COVID-19
por: Della-Torre, Emanuel, et al.
Publicado: (2021)

Hyper-IgG4 disease: report and characterisation of a new disease
por: Neild, Guy H, et al.
Publicado: (2006)

Profound differences in IgE and IgG recognition of micro‐arrayed allergens in hyper‐IgE syndromes
por: Garib, Victoria, et al.
Publicado: (2021)

Anakinra for patients with COVID-19 – Authors' reply
por: Cavalli, Giulio, et al.
Publicado: (2020)

Hyper IgG4-Related Disease Presenting with Orbital Tumor and Immune Deficiency
por: Olson, Caroline G., et al.
Publicado: (2021)

Repurposing of Biologic and Targeted Synthetic Anti-Rheumatic Drugs in COVID-19 and Hyper-Inflammation: A Comprehensive Review of Available and Emerging Evidence at the Peak of the Pandemic
por: Cavalli, Giulio, et al.
Publicado: (2020)

Pathologies Associated with Serum IgG4 Elevation
por: Ebbo, Mikael, et al.
Publicado: (2012)

Subclasses of allergen-specific IgG: Serum IgG2 and IgG3 levels are not predicted by IgG1/IgG4 levels
por: MacGlashan, Donald, et al.
Publicado: (2021)

In Reply: IgG4 Related Disease and Sensorineural Hearing Loss
por: Cho, Han-Kyu, et al.
Publicado: (2014)

IgG4-Related Lung Disease without Elevation of Serum IgG4 Level: A Case Report
por: Kang, Min Kyu, et al.
Publicado: (2016)

Demyelinating Neuropathy with Markedly Elevated Serum IgG4 Levels and Anti-Contactin 1 IgG4 Antibody
por: Fukushima, Taiki, et al.
Publicado: (2022)

Features and outcome of AIH patients without elevation of IgG
por: Hartl, Johannes, et al.
Publicado: (2020)

In reply: the evaluation of IgG titers' stability from blood samples is necessary
por: Ouh, Yung-Taek, et al.
Publicado: (2020)

Authors' Reply
por: Wendler, David, et al.
Publicado: (2006)

The antiinflammatory activity of IgG: the intravenous IgG paradox
por: Nimmerjahn, Falk, et al.
Publicado: (2007)

Atopy and Elevation of IgE, IgG3, and IgG4 May Be Risk Factors for Post COVID-19 Condition in Children and Adolescents
por: Körner, Robert Walter, et al.
Publicado: (2023)

Serum IgG4 levels outperform IgG4/IgG RNA ratio in differential diagnosis of IgG4-related disease
por: Schulte, Lucas A., et al.
Publicado: (2020)

Authors’ reply
por: Dias, Emanuel, et al.
Publicado: (2020)

Interleukin-1 and interleukin-6 inhibition in patients with COVID-19 and hyperinflammation – Authors' reply
por: Cavalli, Giulio, et al.
Publicado: (2021)

Enriched blood IgG sialylation attenuates IgG-mediated and IgG-controlled-IgE-mediated allergic reactions
por: Petry, Janina, et al.
Publicado: (2020)

Association of dengue infection with anti-alpha-gal antibodies, IgM, IgG, IgG1, and IgG2
por: Olajiga, Olayinka M., et al.
Publicado: (2022)

Peripapillary hyper-reflective ovoid mass-like structures (PHOMS) in AQP4-IgG-positive neuromyelitis optica spectrum disease (NMOSD) and MOG-IgG-associated disease (MOGAD)
por: Gernert, Jonathan A., et al.
Publicado: (2022)

Reply to Pandey: Possible functional impact of IgG3 allotype constant region
por: Kallolimath, Somanath, et al.
Publicado: (2022)

Elevated serum IgG4 levels in two cases of paragonimiasis
por: Saeki, Sho, et al.
Publicado: (2015)

Elevated IgG4 serum levels in patients with cystic fibrosis
por: Clerc, Axelle, et al.
Publicado: (2017)

A case of Strongyloides hyperinfection syndrome with elevated IgG4
por: Takao, Ryota, et al.
Publicado: (2023)

A Novel Presentation of Autoimmune Hepatitis with IgG1 Elevation
por: Zhang, Yujiao, et al.
Publicado: (2023)

Specificity of fc receptors for IgG2a, IgG1/IgG2b, and IgE on rat macrophages
Publicado: (1981)

Elevated levels of IgA and IgG2 in individuals with chronic spinal cord injury
por: Shnawa, Aya, et al.
Publicado: (2021)

The Expression of IgG and IgG4 in Orbital MALT Lymphoma: The Similarities and Differences of IgG4-Related Diseases
por: Li, Kai-Ming, et al.
Publicado: (2020)

Activation of SARS-CoV-2 neutralizing antibody is slower than elevation of spike-specific IgG, IgM, and nucleocapsid-specific IgG antibodies
por: Takahashi, Maika, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_73okf9btn2j46qgptimr0iotd0